Patent applications using CG-MALS

P U B L I C AT I O N L I S T PL3010: Key publications on the characterization of protein self-association by CG-MALS Summary This document lists key publications using CG-MALS for the characterization of specific self-association in…

P U B L I C AT I O N L I S T PL5011: Key publications on high-throughput screening of therapeutic protein formulations by light scattering Summary This document lists key publications using high-throughput dynamic and static light scattering…

A P P L I C AT I O N N O T E AN3009: Characterization of self-associating antibody solutions at high concentrations with CG-MALS Sophia Kenrick, Ph.D. and Daniel Some, Ph.D., Waters | Wyatt Technology Summary The characterization of…

PEG-Protein Interactions for Stable Formulations Studied by CG-MALS Daniel Some and Sophia Kenrick, Wyatt Technology Corp., Santa Barbara, CA 93117 1. Background Many therapeutic proteins such as antibodies exhibit non-specific self-association at concentrations > 10 mg/mL typical of final drug-product…